These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 11123062

  • 21. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
    Barbasso Helmers S, Dastmalchi M, Alexanderson H, Nennesmo I, Esbjörnsson M, Lindvall B, Lundberg IE.
    Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
    [Abstract] [Full Text] [Related]

  • 22. Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy.
    Megens-de Letter MA, Visser LH, van Doorn PA, Savelkoul HF.
    Eur Cytokine Netw; 1999 Dec; 10(4):471-8. PubMed ID: 10586113
    [Abstract] [Full Text] [Related]

  • 23. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation.
    De Rossi M, Bernasconi P, Baggi F, de Waal Malefyt R, Mantegazza R.
    Int Immunol; 2000 Sep; 12(9):1329-35. PubMed ID: 10967028
    [Abstract] [Full Text] [Related]

  • 24. Idiopathic inflammatory myopathies.
    Dimachkie MM.
    J Neuroimmunol; 2011 Feb; 231(1-2):32-42. PubMed ID: 21093064
    [Abstract] [Full Text] [Related]

  • 25. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.
    Raju R, Dalakas MC.
    Brain; 2005 Aug; 128(Pt 8):1887-96. PubMed ID: 15857930
    [Abstract] [Full Text] [Related]

  • 26. Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies.
    Confalonieri P, Bernasconi P, Megna P, Galbiati S, Cornelio F, Mantegazza R.
    J Neuropathol Exp Neurol; 2000 Feb; 59(2):164-9. PubMed ID: 10749105
    [Abstract] [Full Text] [Related]

  • 27. Ro52/TRIM21-deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies.
    Gómez-Martín D, Galindo-Feria AS, Barrera-Vargas A, Merayo-Chalico J, Juárez-Vega G, Torres-Ruiz J, Alcocer-Varela J.
    Clin Exp Immunol; 2017 Apr; 188(1):154-162. PubMed ID: 27936488
    [Abstract] [Full Text] [Related]

  • 28. Possible pathogenic mechanisms in inflammatory myopathies.
    Lundberg IE, Dastmalchi M.
    Rheum Dis Clin North Am; 2002 Nov; 28(4):799-822. PubMed ID: 12506773
    [Abstract] [Full Text] [Related]

  • 29. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
    Ernste FC, Reed AM.
    Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
    [Abstract] [Full Text] [Related]

  • 30. Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?
    Loell I, Lundberg IE.
    J Intern Med; 2011 Mar; 269(3):243-57. PubMed ID: 21205023
    [Abstract] [Full Text] [Related]

  • 31. Differential expression of chemokines in inflammatory myopathies.
    De Bleecker JL, De Paepe B, Vanwalleghem IE, Schröder JM.
    Neurology; 2002 Jun 25; 58(12):1779-85. PubMed ID: 12084877
    [Abstract] [Full Text] [Related]

  • 32. Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies.
    Liprandi A, Bartoli C, Figarella-Branger D, Pellissier JF, Lepidi H.
    Acta Neuropathol; 1999 Jun 25; 97(6):642-8. PubMed ID: 10378384
    [Abstract] [Full Text] [Related]

  • 33. Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.
    Moran EM, Mastaglia FL.
    Clin Exp Immunol; 2014 Dec 25; 178(3):405-15. PubMed ID: 25171057
    [Abstract] [Full Text] [Related]

  • 34. Chemokine- and cytokine-induced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells.
    Molet S, Furukawa K, Maghazechi A, Hamid Q, Giaid A.
    J Allergy Clin Immunol; 2000 Feb 25; 105(2 Pt 1):333-8. PubMed ID: 10669855
    [Abstract] [Full Text] [Related]

  • 35. The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseases.
    Adams EM, Kirkley J, Eidelman G, Dohlman J, Plotz PH.
    Proc Assoc Am Physicians; 1997 May 25; 109(3):275-85. PubMed ID: 9154644
    [Abstract] [Full Text] [Related]

  • 36. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.
    Haq SA, Tournadre A.
    Int J Rheum Dis; 2015 Nov 25; 18(8):818-25. PubMed ID: 26385431
    [Abstract] [Full Text] [Related]

  • 37. [Idiopathic inflammatory myopathies. A review].
    Acosta I, Matamala JM, Jara P, Pino F, Gallardo A, Verdugo R.
    Rev Med Chil; 2019 Mar 25; 147(3):342-355. PubMed ID: 31344172
    [Abstract] [Full Text] [Related]

  • 38. Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis.
    Nyberg P, Wikman AL, Nennesmo I, Lundberg I.
    J Rheumatol; 2000 Apr 25; 27(4):940-8. PubMed ID: 10782820
    [Abstract] [Full Text] [Related]

  • 39. [Expression of adhesion molecules in idiopathic inflammatory myopathies. Immunohistochemical study of 17 cases].
    Liprandi A, Figarella-Branger D, Daniel L, Lepidi H, Bartoli C, Pellissier JF.
    Ann Pathol; 1999 Mar 25; 19(1):12-8. PubMed ID: 10320905
    [Abstract] [Full Text] [Related]

  • 40. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
    Sallum AM, Kiss MH, Silva CA, Wakamatsu A, Vianna MA, Sachetti S, Marie SK.
    Autoimmun Rev; 2006 Feb 25; 5(2):93-100. PubMed ID: 16431335
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.